These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 31069577)

  • 1. Association between hyperechogenic pancreas and pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasms.
    Mandai K; Uno K; Nakase K; Kawamura T; Yasuda K
    J Med Ultrason (2001); 2019 Oct; 46(4):435-439. PubMed ID: 31069577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms.
    Kamata K; Kitano M; Kudo M; Sakamoto H; Kadosaka K; Miyata T; Imai H; Maekawa K; Chikugo T; Kumano M; Hyodo T; Murakami T; Chiba Y; Takeyama Y
    Endoscopy; 2014 Jan; 46(1):22-9. PubMed ID: 24218310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of additional endoscopic ultrasonography for surveillance after surgical removal of intraductal papillary mucinous neoplasms.
    Kamata K; Takenaka M; Minaga K; Omoto S; Miyata T; Yamao K; Imai H; Nakai A; Tanaka H; Chiba Y; Watanabe T; Sakurai T; Nishida N; Chikugo T; Matsumoto I; Takeyama Y; Kitano M; Kudo M
    Dig Endosc; 2018 Sep; 30(5):659-666. PubMed ID: 29675938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of 3-T MR imaging in intraductal papillary mucinous neoplasm with a concomitant invasive carcinoma.
    Sotozono H; Kanki A; Yasokawa K; Yamamoto A; Sanai H; Moriya K; Tamada T
    Eur Radiol; 2022 Dec; 32(12):8276-8284. PubMed ID: 35665843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography.
    Harima H; Kaino S; Shinoda S; Kawano M; Suenaga S; Sakaida I
    World J Gastroenterol; 2015 May; 21(20):6252-60. PubMed ID: 26034360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic inflammatory changes and oxidative stress in the background of "pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm".
    Matsuda R; Miyasaka Y; Yamada Y; Kawata J; Sakihama K; Yamamoto T; Saeki K; Yamamoto H; Ohishi Y; Koga Y; Nakamura M; Oda Y
    Virchows Arch; 2020 Dec; 477(6):799-806. PubMed ID: 32468246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dilated common bile duct is commonly associated with main duct Intraductal Papillary Mucinous Neoplasm of the pancreas.
    Sbeit W; Shahin A; Khoury T
    BMC Gastroenterol; 2024 Jun; 24(1):201. PubMed ID: 38886637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant Intraductal Papillary Mucinous Neoplasm in Pancreatic Ductal Adenocarcinoma Is an Independent Predictive Factor for the Occurrence of New Cancer in the Remnant Pancreas.
    Matsuda R; Miyasaka Y; Ohishi Y; Yamamoto T; Saeki K; Mochidome N; Abe A; Ozono K; Shindo K; Ohtsuka T; Kikutake C; Nakamura M; Oda Y
    Ann Surg; 2020 May; 271(5):941-948. PubMed ID: 30308608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of SOX9 expression in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm.
    Tanaka T; Kuroki T; Adachi T; Ono S; Hirabaru M; Soyama A; Kitasato A; Takatsuki M; Hayashi T; Eguchi S
    Pancreas; 2013 Apr; 42(3):488-93. PubMed ID: 23146920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN.
    Kang MJ; Lee KB; Jang JY; Kwon W; Park JW; Chang YR; Kim SW
    Pancreas; 2013 Nov; 42(8):1267-74. PubMed ID: 24308063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifocal cysts and incidence of pancreatic cancer concomitant with intraductal papillary mucinous neoplasm.
    Ikegawa T; Masuda A; Sakai A; Toyama H; Zen Y; Sofue K; Nakagawa T; Shiomi H; Takenaka M; Kobayashi T; Yoshida M; Arisaka Y; Okabe Y; Kutsumi H; Fukumoto T; Azuma T
    Pancreatology; 2018 Jun; 18(4):399-406. PubMed ID: 29685673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinction of Invasive Carcinoma Derived From Intraductal Papillary Mucinous Neoplasms From Concomitant Ductal Adenocarcinoma of the Pancreas Using Molecular Biomarkers.
    Tamura K; Ohtsuka T; Date K; Fujimoto T; Matsunaga T; Kimura H; Watanabe Y; Miyazaki T; Ohuchida K; Takahata S; Ishigami K; Oda Y; Mizumoto K; Nakamura M; Tanaka M
    Pancreas; 2016 Jul; 45(6):826-35. PubMed ID: 26646266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical FAP Expression Reflects
    Spektor AM; Gutjahr E; Lang M; Glatting FM; Hackert T; Pausch T; Tjaden C; Schreckenberger M; Haberkorn U; Röhrich M
    J Nucl Med; 2024 Jan; 65(1):52-58. PubMed ID: 38167622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic Neuroendocrine Neoplasm Concomitant with Branch-duct Intraductal Papillary Mucinous Neoplasm: A Case Report and Literature Review.
    Sawai Y; Asada M; Marusawa H
    Intern Med; 2024 Sep; 63(17):2427-2432. PubMed ID: 38296477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of endoscopic retrograde pancreatography for early detection of pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm of the pancreas.
    Ohtsuka T; Ideno N; Aso T; Nagayoshi Y; Kono H; Mori Y; Takahata S; Oda Y; Aishima S; Igarashi H; Ito T; Ishigami K; Nakamura M; Mizumoto K; Tanaka M
    J Hepatobiliary Pancreat Sci; 2013 Mar; 20(3):356-61. PubMed ID: 22878836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms.
    Oyama H; Tada M; Takagi K; Tateishi K; Hamada T; Nakai Y; Hakuta R; Ijichi H; Ishigaki K; Kanai S; Kogure H; Mizuno S; Saito K; Saito T; Sato T; Suzuki T; Takahara N; Morishita Y; Arita J; Hasegawa K; Tanaka M; Fukayama M; Koike K
    Gastroenterology; 2020 Jan; 158(1):226-237.e5. PubMed ID: 31473224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic ultrasound-guided fine-needle aspiration cytology diagnosis of intraductal papillary mucinous neoplasm of the pancreas is highly predictive of pancreatic neoplasia.
    Emerson RE; Randolph ML; Cramer HM
    Diagn Cytopathol; 2006 Jul; 34(7):457-62. PubMed ID: 16783773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of multiphase contrast enhancement patterns on CEH-EUS for the differential diagnosis of IPMN-derived and conventional pancreatic cancer.
    Yashika J; Ohno E; Ishikawa T; Iida T; Suzuki H; Uetsuki K; Yamada K; Yoshikawa M; Gibo N; Shimoyama Y; Ishikawa E; Furukawa K; Nakamura M; Honda T; Ishigami M; Hirooka Y; Kawashima H; Fujishiro M
    Pancreatology; 2021 Mar; 21(2):390-396. PubMed ID: 33487577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-grade dysplasia and adenocarcinoma are frequent in side-branch intraductal papillary mucinous neoplasm measuring less than 3 cm on endoscopic ultrasound.
    Wong J; Weber J; Centeno BA; Vignesh S; Harris CL; Klapman JB; Hodul P
    J Gastrointest Surg; 2013 Jan; 17(1):78-84; discussion p.84-5. PubMed ID: 22948841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms.
    Sawai Y; Yamao K; Bhatia V; Chiba T; Mizuno N; Sawaki A; Takahashi K; Tajika M; Shimizu Y; Yatabe Y; Yanagisawa A
    Endoscopy; 2010 Dec; 42(12):1077-84. PubMed ID: 21120776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.